Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

EBMT 2020 | International cooperation in BMT and cellular therapy

Anna Sureda • 1 Sep 2020
EBMT 2020
General Leukemia Lymphoma CAR-T

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Barcelona, Spain, discusses the significance of collaborative international studies in bone marrow transplant (BMT) and cellular therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Anna Sureda

Ask the Expert: Anna Sureda answers your lymphoma questions at EHA 2025 8:15
Ask the Expert: Anna Sureda answers your lymphoma questions at EHA 2025
Anna Sureda • 14 Jun 2025
The potential of Glofit-GemOx as a new standard of care in R/R DLBCL 1:32
The potential of Glofit-GemOx as a new standard of care in R/R DLBCL
Anna Sureda • 31 Mar 2025
Optimizing bridging therapy strategies before CAR T-cell therapy 2:10
Optimizing bridging therapy strategies before CAR T-cell therapy
Anna Sureda • 31 Mar 2025
EBV+ PTLD: clinical perspectives & insights into EBV-driven cell therapy 2:01
EBV+ PTLD: clinical perspectives & insights into EBV-driven cell therapy
Anna Sureda • 31 Mar 2025

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals